•
Jun 30, 2021

Cocrystal Pharma Q2 2021 Earnings Report

EPS
-$0.48
Previous year: -$0.84
-42.9%
Cash and Equivalents
$67.1M
Previous year: $19.3M
+247.2%
Free Cash Flow
-$2.64M
Previous year: -$2.33M
+13.4%
Total Assets
$87.4M
Previous year: $40.5M
+116.0%

Cocrystal Pharma

Cocrystal Pharma